TY - JOUR
T1 - Metabolic engineering of Synechococcus elongatus PCC 7942 for improvement of 1,3-propanediol and glycerol production based on in silico simulation of metabolic flux distribution
AU - Hirokawa, Yasutaka
AU - Matsuo, Shingo
AU - Hamada, Hiroyuki
AU - Matsuda, Fumio
AU - Hanai, Taizo
N1 - Funding Information:
This study was financially supported by the Core Research of Evolutional Science and Technology program (CREST) from the Japan Science and Technology Agency (JST).
Publisher Copyright:
© 2017 The Author(s).
PY - 2017/11/25
Y1 - 2017/11/25
N2 - Background: Production directly from carbon dioxide by engineered cyanobacteria is one of the promising technologies for sustainable future. Previously, we have successfully achieved 1,3-propanediol (1,3-PDO) production using Synechococcus elongatus PCC 7942 with a synthetic metabolic pathway. The strain into which the synthetic metabolic pathway was introduced produced 3.48mM (0.265g/L) 1,3-PDO and 14.3mM (1.32g/L) glycerol during 20days of incubation. In this study, the productivities of 1,3-PDO were improved by gene disruption selected by screening with in silico simulation. Methods: First, a stoichiometric metabolic model was applied to prediction of cellular metabolic flux distribution in a 1,3-PDO-producing strain of S. elongatus PCC 7942. A genome-scale model of S. elongatus PCC 7942 constructed by Knoop was modified by the addition of a synthetic metabolic pathway for 1,3-PDO production. Next, the metabolic flux distribution predicted by metabolic flux balance analysis (FBA) was used for in silico simulation of gene disruption. As a result of gene disruption simulation, NADPH dehydrogenase 1 (NDH-1) complexes were found by screening to be the most promising candidates for disruption to improve 1,3-PDO production. The effect of disruption of the gene encoding a subunit of the NDH-1 complex was evaluated in the 1,3-PDO-producing strain. Results and Conclusions: During 20days of incubation, the ndhF1-null 1,3-PDO-producing strain showed the highest titers: 4.44mM (0.338g/L) 1,3-PDO and 30.3mM (2.79g/L) glycerol. In this study, we successfully improved 1,3-PDO productivity on the basis of in silico simulation of gene disruption.
AB - Background: Production directly from carbon dioxide by engineered cyanobacteria is one of the promising technologies for sustainable future. Previously, we have successfully achieved 1,3-propanediol (1,3-PDO) production using Synechococcus elongatus PCC 7942 with a synthetic metabolic pathway. The strain into which the synthetic metabolic pathway was introduced produced 3.48mM (0.265g/L) 1,3-PDO and 14.3mM (1.32g/L) glycerol during 20days of incubation. In this study, the productivities of 1,3-PDO were improved by gene disruption selected by screening with in silico simulation. Methods: First, a stoichiometric metabolic model was applied to prediction of cellular metabolic flux distribution in a 1,3-PDO-producing strain of S. elongatus PCC 7942. A genome-scale model of S. elongatus PCC 7942 constructed by Knoop was modified by the addition of a synthetic metabolic pathway for 1,3-PDO production. Next, the metabolic flux distribution predicted by metabolic flux balance analysis (FBA) was used for in silico simulation of gene disruption. As a result of gene disruption simulation, NADPH dehydrogenase 1 (NDH-1) complexes were found by screening to be the most promising candidates for disruption to improve 1,3-PDO production. The effect of disruption of the gene encoding a subunit of the NDH-1 complex was evaluated in the 1,3-PDO-producing strain. Results and Conclusions: During 20days of incubation, the ndhF1-null 1,3-PDO-producing strain showed the highest titers: 4.44mM (0.338g/L) 1,3-PDO and 30.3mM (2.79g/L) glycerol. In this study, we successfully improved 1,3-PDO productivity on the basis of in silico simulation of gene disruption.
UR - http://www.scopus.com/inward/record.url?scp=85034810255&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85034810255&partnerID=8YFLogxK
U2 - 10.1186/s12934-017-0824-4
DO - 10.1186/s12934-017-0824-4
M3 - Article
C2 - 29178875
AN - SCOPUS:85034810255
SN - 1475-2859
VL - 16
JO - Microbial Cell Factories
JF - Microbial Cell Factories
IS - 1
M1 - 212
ER -